Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine CALGAR
|
11
|
Resverlogix Corp.
|
Mar 17, 2022 07:22AM
|
Resverlogix to Present at Upcoming Conferences
|
2
|
Resverlogix Corp.
|
Oct 13, 2021 09:04AM
|
To a better new year.
|
5
|
Resverlogix Corp.
|
Dec 31, 2020 11:16PM
|
Login a Go...
|
1
|
Resverlogix Corp.
|
Dec 22, 2020 02:44PM
|
Link
|
1
|
Zenith Epigenetics
|
Mar 05, 2020 07:01AM
|
Looking forward
|
|
Resverlogix Corp.
|
Nov 16, 2019 11:19AM
|
Now we wait.......
|
2
|
Resverlogix Corp.
|
Oct 28, 2019 05:35AM
|
Now we wait.......
|
5
|
Resverlogix Corp.
|
Sep 27, 2019 04:01PM
|
Almost to a Billion Dollar market cap.
|
2
|
Resverlogix Corp.
|
May 08, 2019 10:02AM
|
NASDAQ here we come!!!
|
4
|
Resverlogix Corp.
|
Apr 23, 2019 11:31AM
|
Re: Contest Tally
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 01:37PM
|
Td waterhouse
|
3
|
Zenith Epigenetics
|
Sep 07, 2018 09:53AM
|
ZENITH at 2.00
|
2
|
Resverlogix Corp.
|
Sep 07, 2018 09:50AM
|
Here's to New 52 week highs
|
1
|
Resverlogix Corp.
|
Sep 05, 2018 12:59PM
|
Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
|
5
|
Resverlogix Corp.
|
Aug 07, 2018 07:12AM
|
Re: Resverlogix Announces Upcoming Presentations at Clinical Trials in Alzheimer’s Disease (CTAD) Asia and Alzheimer’s Association International Conferenc
|
3
|
Resverlogix Corp.
|
Jul 17, 2018 07:13AM
|
Resverlogix Announces Upcoming Presentations at Clinical Trials in Alzheimer’s Disease (CTAD) Asia and Alzheimer’s Association International Conferenc
|
2
|
Resverlogix Corp.
|
Jul 17, 2018 07:11AM
|
Resverlogix Announces Proposed Offering of Units
|
2
|
Resverlogix Corp.
|
Apr 17, 2018 09:16AM
|
Re: webcast?
|
|
Resverlogix Corp.
|
Dec 12, 2017 03:43PM
|
Great Job group
|
4
|
Zenith Epigenetics
|
Mar 10, 2016 09:47AM
|